← Back to all trials
Not Yet Recruiting
NCT05629299
Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM
Conditions: Monkeypox
Sex: Male
Ages: 18 Years – 50 Years
Phase: NA
Enrollment: 30
Sponsor: University Hospital, Toulouse
Location: France
Summary
Given the current emerging epidemic of the MonkeyPox Virus (MPXV) and its route of transmission, the main objective of this pilot study is to characterize the presence of the MPXV in the semen of patients in the acute phase of infection and following this infection.
Eligibility Criteria
Inclusion Criteria:in the acute phase of MPXV infection and whose PCR reveals the viral genome in a skin sample or in any other sample.able to travel to the laboratory for the sampleswho gave his free and informed consent and having signed the consentPatient affiliated to a social security scheme or equivalentExclusion Criteria:Patient who has previously consulted for male infertility or who has previously performed an abnormal semen test (WHO standard)Patient with ejaculation disorder or unable to collect semen or with abnormal semen volume (<1.5 mL).Patient who presents serious clinical signs that do not allow him to travel to the investigation center.Patient under a protection regime (including guardianship, curatorship or safeguard of justice)
Source: ClinicalTrials.gov (NCT05629299). StuddyBuddy aggregates publicly available trial information.